Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders.
J Formos Med Assoc
; 121(12): 2538-2547, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35752529
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Triple Negative Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
J Formos Med Assoc
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Singapur